Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
RxNorm 106507
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 106507 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Papaveretum 15.4 mg/ML / scopolamine 0.4 mg/ML Injectable Solution
(Atom ID: 12335828)
SY
Synonym (SY):
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection
(Atom ID: 10804765)
PT
Designated preferred name (PT):
Papaveretum 15.4 mg/mL and scopolamine hydrobromide 400 microgram/mL solution for injection
(Atom ID: 10808614)
FN